Pulmonary aspergillosis in patients with asthma
The Journal of Infection in Developing Countries · 30.06.2025 · 19 (06) · 804-811
DOI: 10.3855/jidc.20711 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 30.06.2025. Verfasst von Mihailo Stjepanovic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Pulmonology, University Clinical Center of Serbia, Belgrade, Serbia. Hauptthemen laut MEDLINE: Asthma, Aspergillosis, Allergic Bronchopulmonary, Pulmonary Aspergillosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Asthma is a complex respiratory condition characterized by airway inflammation and hyper-responsiveness, and poses a significant global health burden, affecting millions worldwide. Its origins lie in interactions between genetic, environmental, and host factors. While typically manageable, asthma can lead to severe exacerbations and complications if left untreated. The association between asthma and fungal infections, particularly with Aspergillus species, has garnered attention due to its impact on disease severity and management. We aim to provide a comprehensive overview of this association focusing on its various clinical presentations, risk factors, diagnostic approaches, and treatment strategies. Allergic bronchopulmonary aspergillosis (ABPA) emerges as a prevalent form of aspergillosis in asthmatic individuals, presenting challenges in both diagnosis and management. We discuss the evolving diagnostic criteria for ABPA, emphasizing the importance of clinical suspicion, radiological findings, serological tests, and pulmonary function tests. Moreover, we address the therapeutic interventions, review the roles of systemic glucocorticoids, antifungal agents, and emerging novel therapeutic agents. Early detection and intervention in fungal infections in asthma patients, particularly ABPA, are essential to mitigate exacerbations, improve symptom control, and prevent severe complications. This review underscores the necessity for heightened awareness and proactive management of fungal infections in the context of asthma, aiming to enhance patient care and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic for Pulmonology, University Clinical Center of Serbia, Belgrade, Serbia.
- Medical Faculty, University of Belgrade, Belgrade, Serbia.
Zitieren
APA
Stjepanovic, M., Barac, A., Golubovic, A., Markovic, F., Krajišnik, S., & Jankovic, J. (2025). Pulmonary aspergillosis in patients with asthma. The Journal of Infection in Developing Countries, 19(06), 804-811. https://doi.org/10.3855/jidc.20711
Vancouver
Stjepanovic M, Barac A, Golubovic A, Markovic F, Krajišnik S, Jankovic J. Pulmonary aspergillosis in patients with asthma. The Journal of Infection in Developing Countries. 2025;19(06):804-811. doi:10.3855/jidc.20711
BibTeX
@article{Stjepanovic2025,
author = {Stjepanovic, Mihailo and Barac, Aleksandra and Golubovic, Aleksa and Markovic, Filip and Krajišnik, Snježana and Jankovic, Jelena},
title = {Pulmonary aspergillosis in patients with asthma},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
volume = {19},
number = {06},
pages = {804--811},
doi = {10.3855/jidc.20711}
}
EUVIMED